Universal Transplant Diagnostics Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Transplant Diagnostics Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Transplant Diagnostics Market – Overview
Antibody-mediated refusal of organ allografts is difficult to treat as barriers following allotransplantation. Enhanced diagnostics has permitted better detection and specificity-determination of antibodies precise for a donor Human Leukocyte Antigens (HLA). Nevertheless, antibodies which are also against non-HLA antigens are of importance for graft function. We have established a novel crossmatch test that simplifies detection of donor-specific non-HLA particular antibodies prior to transplantation. Doctors and expert physicians are presently refining this test which allows detection of complement-fixing non-HLA antibodies. Additionally, studies are going on to assess the occurrence of non-HLA specific antibodies in kidney graft inheritors post-transplant as well as at the time of rejection. A substantial problem in clinical transplantation is the lack of donor tissue/organs for transplantation. One of the possible solutions to this problem is the use of tissues/organs/ cells from animals for transplantation to man, which is also known as xenotransplantation. Because xenografts are dynamically rejected, studies on the reasons for this rejection are essential. In particular specialists are interested in evaluating co-stimulation blockade as a means of undertaking long-term pancreatic islet xenograft survival. Global transplant diagnostics market is expected to grow at a CAGR of 7.2% during forecasted period 2017-2023.
Request Sample Pages @ https://www.marketresearchfuture.com/sample_request/1324 .
Further Transplantation of organs, tissues and cells are now effective therapies across a wide range of both fatal and non-fatal diseases. The outstanding survival and success rates of transplantation of organs and cells, such as the kidney, liver and heart or haematopoietic stem cells in immunosuppressed patients, have led to extraordinary levels of demand globally. The rate of success for transplantation of certain cells or tissues which do not involve immunosuppression have also confirmed that such procedures are regularly the treatment of choice in the respective therapeutic areas. It is, nevertheless, clear that ethically-unacceptable practices occur in a number of countries globally. In spite of the appropriate focus on prevention of the disease, the global needs of patients for transplantation are not being met. The demand has surpassed the supply of organs, cells and tissues from both deceased donors and from the unselfish living relatives of patients in need of organs. The alternate treatments and medical support for patients with end stage organ failure, particularly renal dialysis, are expensive and narrowed down in various countries globally. There is also a lack of clinical expertise in some regions and countries and an incapability for fund transplantation to some extent in all countries around the world.
Key Players for Global Transplant Diagnostics Market:
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US).
Global Transplant Diagnostics Market – Competitive Analysis
Thermo Fisher Scientific Acquires Linkage Bio: on July 2017 Thermo Fisher Scientific confirmed the company’s acquisition of Linkage Biosciences for an undisclosed amount, as a result of this acquisition Linkage Biosciences is now a part of Thermo Fisher’s transplant diagnostics business. The company based in South San Francisco, California. Benefits involved from the acquisition include a broader and deeper range of products, a continued commitment to innovation, and expanded support globally.
The business is extremely complementary to the company’s One Lambda tests, which regulate the compatibility of donors and recipients pre- and post-transplant. This acquisition further expands Thermo Fisher’s commitment of improving transplant patients’ quality of life over innovative high-quality products for the clinical and research segments of the transplant community.
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US) are some of the major players in the Global Transplant Diagnostics Market.
Global Transplant Diagnostics Market is segmented on the basis of products into instrument, reagent, software and services. On the basis of technology the market is segmented into non-molecular assay and molecular assay. Non-molecular is further segmented into serological assay and mixed lymphocyte culture. Molecular assay is further segmented into sequenced base and PCR based. On the basis of application the market is segmented into heart, lungs, liver, and kidney and other. On the basis of method type the market is segmented into pre-transplant screening and post-transplant screening and on the basis of end user the market is segmented as hospitals, transplants centres, research laboratories and other.
TOC of Transplant Diagnostics Market:
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS
5.3 SOFTWARE AND SERVICES
6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 NON-MOLECULAR ASSAY
6.1.1 SEROLOGICAL ASSAY
6.1.2 MIXED LYMPHOCYTE CULTURE
6.2 MOLECULAR ASSAY
6.2.1 SEQUENCED BASE
6.2.2 PCR BASED
7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION
Key Questions Answered In This Report:
What will the market size and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Avail Marvelous Discount @ https://www.marketresearchfuture.com/check-discount/1324 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312